|
biomedicina slovenica |
"Anastrozol" : 9
-
Tryfonidis Konstantinos; Čufer Tanja
A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378).
2016 ►
-
Rakuša Matej; Čokolič Miro
Obravnava bolnice z osteoporozo, s hormonsko odvisnim karcinomom dojk in z dolgotrajnim zdravljenjem z anastrozolom
2012 ►
-
Piškur Peter; Sonc Monika; Čufer Tanja; Borštnar Simona; Mrhar Aleš
Pharmacoeconomic aspects of adjuvant anastrozole or tamoxifen in breast cancer: #a #Slovenian perspective
2006 ►
-
Snoj Nataša; Drev Primož; Golouh Rastko; Čufer Tanja
The response to treatment with anastrozole and tamoxifen in HER2 positive breast cancer patients
2005 ►
-
Snoj Nataša; Drev Primož; Pajk Bojana; Borštnar Simona; Golouh Rastko; Čufer Tanja
The response to treatment with anastrozole in HER2 positive metastatic breast cancer patients
2004 ►
-
Piškur Peter; Sonc Monika; Čufer Tanja; Borštnar Simona; Mrhar Aleš
Pharmacoeconomic aspects of adjuvant early breast cancer (EBC) treatment in postmenopausal women with anastrozole (A) or tamoxifen (T): Slovenian perspective
2004 ►
-
Piškur Peter; Sonc Monika; Čufer Tanja; Borštnar Simona; Mrhar Aleš
Pharmacoeconomic aspects of adjuvant early breast cancer (EBC) treatment in postmenopausal women with anastrozole (A) or tamoxifen (T): Slovenian perspective
2004 ►
-
Drev P; Golouh R; Snoj Nataša; Čufer T
Correlation between Her-2 status in primary tumour and response to anastrozole in patients with metastatic breast cancer
2004 ►
-
Piškur P; Sonc M; Čufer T; Borštnar S; Mrhar A
Pharmacoeconomics aspects of adjuvant early breast cancer treatment in postmenopausal women with anastrozole or tamoxifen: a Slovenian perspective
2004 ►
New search
Comments
Top of page
Institute for Biostatistics and Medical Informatics